←Back to structures
MN270258.1__QGJ85309.1__X__00082
Bact-VirMN270258.1__QGJ85309.1__X__00082
Identity
- Accession:
- MN270258 ↗
- Kingdom:
- phage
Quality
76.2
mean pLDDT
Taxonomy
TaxID: 2664388
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 64-191
Domain cluster:
representative
CATH (47)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.76 | 69.0 | 6.70e-01 | 95.3% | 91.3% |
| 3ub1A01 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 67.0 | 6.54e-01 | 97.7% | 88.2% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.75 | 69.0 | 6.60e-01 | 97.7% | 91.7% |
| 5i97C00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.74 | 66.0 | 6.46e-01 | 95.3% | 95.6% |
| 3eyrA00 | 3.15.10.40 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Uncharacterised protein PF07273 family, DUF1439 | 0.73 | 51.0 | 4.58e-01 | 95.3% | 53.3% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 64.0 | 6.39e-01 | 95.3% | 91.0% |
| 1idpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 65.0 | 6.19e-01 | 97.7% | 94.6% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 67.0 | 6.47e-01 | 100.0% | 95.8% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 62.0 | 5.96e-01 | 95.3% | 90.5% |
| 7f13A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 61.0 | 5.84e-01 | 95.3% | 81.2% |
| 2i9wA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 55.0 | 4.94e-01 | 92.2% | 60.8% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.69 | 46.0 | 4.16e-01 | 96.1% | 50.0% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 62.0 | 6.30e-01 | 99.2% | 97.6% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 6.08e-01 | 100.0% | 94.6% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 60.0 | 5.95e-01 | 96.9% | 88.7% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 61.0 | 6.13e-01 | 95.3% | 93.9% |
| 3f7xA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 61.0 | 6.04e-01 | 94.5% | 90.2% |
| 3er7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 59.0 | 6.01e-01 | 96.9% | 95.1% |
| 2gtlO02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.69 | 45.0 | 4.14e-01 | 95.3% | 51.5% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 61.0 | 6.07e-01 | 94.5% | 93.1% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 60.0 | 5.52e-01 | 95.3% | 76.2% |
| 2rfrA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 63.0 | 5.90e-01 | 100.0% | 86.4% |
| 3ejvA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 60.0 | 5.59e-01 | 95.3% | 94.3% |
| 1q42A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 60.0 | 5.60e-01 | 95.3% | 93.7% |
| 3nv0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 60.0 | 5.18e-01 | 95.3% | 86.2% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 58.0 | 5.86e-01 | 97.7% | 90.7% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 59.0 | 5.83e-01 | 95.3% | 90.2% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 59.0 | 6.00e-01 | 94.5% | 97.6% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 58.0 | 5.81e-01 | 94.5% | 91.4% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 60.0 | 5.44e-01 | 95.3% | 86.8% |
| 3cnxA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 62.0 | 6.04e-01 | 100.0% | 93.5% |
| 3ff0A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 58.0 | 5.63e-01 | 95.3% | 85.8% |
| 1q40D00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.22e-01 | 95.3% | 92.0% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 56.0 | 5.76e-01 | 97.7% | 98.3% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 58.0 | 5.14e-01 | 95.3% | 84.2% |
| 1of5B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 56.0 | 5.63e-01 | 95.3% | 95.3% |
| 2ch9A01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 45.0 | 4.78e-01 | 94.5% | 88.5% |
| 2rckA01 | 3.15.10.30 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › TULIP domain | 0.58 | 51.0 | 4.24e-01 | 95.3% | 63.8% |
| 1wpuA00 | 3.40.1510.10 | Alpha Beta › 3-Layer(aba) Sandwich › Hut operon positive regulatory protein HutP › Hut operon regulatory protein HutP | 0.56 | 43.0 | 4.11e-01 | 80.5% | 96.6% |
| 4rlcA00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.56 | 49.0 | 4.85e-01 | 97.7% | 89.6% |
| 4akrA02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.55 | 40.0 | 3.85e-01 | 75.8% | 84.4% |
| 2obdA01 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.54 | 47.0 | 3.68e-01 | 96.1% | 43.5% |
| 4kghA00 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.53 | 46.0 | 4.04e-01 | 95.3% | 63.7% |
| 1dr9A02 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.52 | 27.0 | 3.06e-01 | 92.2% | 63.2% |
| 3zpmA00 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.51 | 44.0 | 3.79e-01 | 95.3% | 60.7% |
| 1olzA01 | 2.130.10.10 | Mainly Beta › 7 Propeller › Methylamine Dehydrogenase; Chain H › YVTN repeat-like/Quinoprotein amine dehydrogenase | 0.51 | 46.0 | 3.12e-01 | 100.0% | 46.1% |
| 3aa0B02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.50 | 36.0 | 3.48e-01 | 75.8% | 84.5% |
ECOD (56)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3288890 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.80 | 69.0 | 6.87e-01 | 91.4% | 88.5% |
| 3941713 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.79 | 69.0 | 6.73e-01 | 93.0% | 95.0% |
| 3962486 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.77 | 67.0 | 6.30e-01 | 98.4% | 76.6% |
| 3587514 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.75 | 67.0 | 6.66e-01 | 99.2% | 92.3% |
| 5059048 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.73 | 65.0 | 6.63e-01 | 95.3% | 96.7% |
| 3278632 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 64.0 | 6.33e-01 | 95.3% | 92.6% |
| 3728760 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 64.0 | 5.87e-01 | 95.3% | 80.0% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.72 | 64.0 | 6.46e-01 | 97.7% | 96.0% |
| 3290450 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.71 | 63.0 | 6.13e-01 | 95.3% | 86.0% |
| 3732871 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.71 | 63.0 | 5.61e-01 | 95.3% | 80.3% |
| 3960625 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 63.0 | 6.01e-01 | 95.3% | 90.7% |
| 3588483 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 61.0 | 6.05e-01 | 95.3% | 89.6% |
| 4479712 | 243.1.1.3 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Scytalone_dh | 0.70 | 64.0 | 5.72e-01 | 100.0% | 92.8% |
| 3782298 | 243.1.1.14 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Mtr2 | 0.70 | 62.0 | 5.56e-01 | 95.3% | 93.7% |
| 4593105 | 243.1.1.3 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Scytalone_dh | 0.70 | 53.0 | 5.43e-01 | 79.7% | 95.2% |
| 4080326 | 243.1.1.76 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF25976 | 0.70 | 54.0 | 5.56e-01 | 92.2% | 85.8% |
| 3283278 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.70 | 62.0 | 6.12e-01 | 95.3% | 94.1% |
| 3515333 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.70 | 47.0 | 5.50e-01 | 94.5% | 98.9% |
| 135742 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.69 | 62.0 | 6.03e-01 | 95.3% | 87.7% |
| 4162701 | 243.1.1.76 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF25976 | 0.69 | 53.0 | 5.49e-01 | 92.2% | 85.8% |
| 1094951 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.69 | 60.0 | 5.52e-01 | 95.3% | 76.2% |
| 3764790 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.68 | 46.0 | 5.26e-01 | 93.0% | 92.6% |
| 4927707 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.68 | 61.0 | 5.92e-01 | 97.7% | 95.0% |
| 4884000 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.68 | 60.0 | 5.59e-01 | 94.5% | 92.3% |
| 5032792 | 4252.1.1.0 ↗ | beta barrels › AttH-like › AttH-like › AttH-like | 0.67 | 41.0 | 3.98e-01 | 80.5% | 54.3% |
| 3293799 | 243.1.1.24 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › ARC6-like_IMS | 0.67 | 61.0 | 5.76e-01 | 98.4% | 83.3% |
| 3281948 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.67 | 56.0 | 5.84e-01 | 90.6% | 95.0% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.65 | 56.0 | 5.76e-01 | 97.7% | 98.3% |
| 169776 | 243.1.1.4 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PHZA_PHZB | 0.65 | 58.0 | 5.34e-01 | 95.3% | 76.5% |
| 3773175 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.62 | 47.0 | 4.17e-01 | 96.1% | 55.1% |
| 4343712 | 243.1.1.76 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF25976 | 0.61 | 49.0 | 5.08e-01 | 91.4% | 92.5% |
| 3936676 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.61 | 41.0 | 4.69e-01 | 93.0% | 92.6% |
| 3604270 | 283.2.1.0 ↗ | a+b duplicates or obligate multimers › Creatinase/aminopeptidase-like › gpW/gp25-like › gpW/gp25-like | 0.60 | 39.0 | 3.92e-01 | 85.9% | 63.8% |
| 3165475 | 5084.1.1.4 ↗ | beta barrels › Outer membrane meander beta-barrels › OMPA-like › OMPA-like › Opacity | 0.59 | 52.0 | 4.85e-01 | 93.8% | 88.6% |
| 3597592 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.59 | 52.0 | 4.49e-01 | 98.4% | 76.1% |
| 3750494 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.59 | 51.0 | 4.38e-01 | 95.3% | 62.0% |
| 3700510 | 243.1.1.94 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26532 | 0.58 | 52.0 | 4.50e-01 | 98.4% | 78.0% |
| 3285112 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.57 | 44.0 | 3.92e-01 | 95.3% | 55.8% |
| 3800723 | 883.1.1.2 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP_C | 0.57 | 50.0 | 4.03e-01 | 95.3% | 54.7% |
| 4464656 | 883.1.1.2 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP_C | 0.57 | 48.0 | 3.87e-01 | 95.3% | 45.9% |
| 3875620 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.54 | 50.0 | 4.33e-01 | 98.4% | 80.5% |
| 3461207 | 11.1.1.51 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like › LEA_2 | 0.54 | 41.0 | 3.87e-01 | 81.2% | 90.6% |
| 3715923 | 5.1.3.28 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 6-bladed › BNR_3 | 0.54 | 49.0 | 3.40e-01 | 100.0% | 43.1% |
| 3764436 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.53 | 43.0 | 3.94e-01 | 96.1% | 64.6% |
| 3434245 | 9.3.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › DUF2921_N | 0.53 | 47.0 | 4.25e-01 | 95.3% | 89.4% |
| 3530920 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.53 | 46.0 | 3.96e-01 | 96.1% | 64.4% |
| None | — | 0.53 | 40.0 | 3.18e-01 | 93.0% | 38.1% | |
| 4647627 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.52 | 45.0 | 3.84e-01 | 95.3% | 59.1% |
| 3760087 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.52 | 42.0 | 3.61e-01 | 96.1% | 53.7% |
| 1102013 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.52 | 44.0 | 3.86e-01 | 95.3% | 62.1% |
| 3646327 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.52 | 39.0 | 3.67e-01 | 95.3% | 64.4% |
| 3541529 | 883.1.1.15 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP+LBP_BPI_CETP_C | 0.51 | 45.0 | 3.13e-01 | 96.1% | 30.9% |
| 3627039 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.51 | 44.0 | 3.63e-01 | 95.3% | 52.7% |
| 3802939 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.51 | 39.0 | 3.67e-01 | 82.8% | 97.0% |
| 4096366 | 330.6.1.1 ↗ | a+b two layers › dsRBD-like › 2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain › 2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain › LeuA_dimer | 0.50 | 38.0 | 3.90e-01 | 78.9% | 85.6% |
| 3807704 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.50 | 43.0 | 4.13e-01 | 93.8% | 84.0% |